- Ongoing, recruitingHuman Pharmacology (Phase I)- Other
Open-Label Pilot Trial to Evaluate the Effects of Ilofotase Alfa on Biomarkers in Adult Patients with Hypophosphatasia
This study is looking at a new medicine called ilofotase alfa for adults with a rare bone condition called hypophosphatasia (HPP). We want to see how different doses of this medicine might change important markers in the body.
For: HypophosphatasiaGermany - Ongoing, recruitingTherapeutic exploratory (Phase II)
Double-Blind, Randomized, Placebo-Controlled Trial to Evaluate the Efficacy and Safety of Ilofotase Alfa in Patients at Risk for Renal Damage Following Open Heart Surgery.
This study is testing a new medicine, Ilofotase alfa, for people having open-heart surgery. It aims to see if the medicine can help protect their kidneys and prevent damage after the operation. Researchers are comparing it to a dummy medicine.
For: Risk for renal damage following open heart surgeryGermany · Belgium · Netherlands